Shivaram P Singh
Overview
Explore the profile of Shivaram P Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anirvan P, Khan Z, Bhuyan P, Dixit S, Dash R, Mishra P, et al.
J Clin Exp Hepatol
. 2025 Feb;
15(3):102503.
PMID: 39996103
Background/objectives: There are very few comparative studies worldwide between 'lean' and 'nonlean/obese nonalcoholic fatty liver disease (NAFLD)' patients analyzing the differences in gut microbiome, genotype, and serum bile acids. Our...
2.
Singh S, Sudhamshu K, Anirvan P, Shrestha A, Al Mahtab M
Euroasian J Hepatogastroenterol
. 2024 Jul;
14(1):1-4.
PMID: 39022204
Singh SP, Sudhamshu KC, Anirvan P, . Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name? Euroasian J Hepato-Gastroenterol 2024;14(1):1-4.
3.
Kumar A, Acharya S, Singh S, Duseja A, Madan K, Shukla A, et al.
J Clin Exp Hepatol
. 2023 Dec;
14(1):101269.
PMID: 38107186
Hepatocellular carcinoma (HCC) presents significant treatment challenges despite considerable advancements in its management. The Indian National Association for the Study of the Liver (INASL) first published its guidelines to aid...
4.
Anirvan P, Khatua C, Panigrahi M, Singh S
J Clin Exp Hepatol
. 2023 Dec;
14(2):101301.
PMID: 38076441
No abstract available.
5.
Arora U, Goyal R, Teh K, Pei Y, Goh G, Lin S, et al.
Dig Dis Sci
. 2023 Sep;
68(12):4485-4498.
PMID: 37733130
Background: Non-invasive tests (NITs) are useful to assess advanced fibrosis (AF) in nonalcoholic fatty liver disease (NAFLD). Data from Asian countries suggest that these tests have poor performance. We aimed...
6.
Krag A, Buti M, Lazarus J, Allen A, Bowman J, Burra P, et al.
J Hepatol
. 2023 Aug;
79(5):1076-1078.
PMID: 37634993
No abstract available.
7.
Singh S, Anirvan P
J Clin Exp Hepatol
. 2023 May;
13(3):547-548.
PMID: 37250879
No abstract available.
8.
Singh S, Duseja A, Al Mahtab M, Anirvan P, Acharya S, Akbar S, et al.
J Clin Exp Hepatol
. 2023 May;
13(3):518-522.
PMID: 37250868
There is an ongoing debate on the change of terminology of non-alcoholic fatty liver disease (NAFLD) to metabolic associated fatty liver disease (MAFLD). Experts from the Indian National Association for...
9.
Khatua C, Panigrahi M, Choudhury A, Nath G, Khandelwal R, Anirvan P, et al.
J Clin Exp Hepatol
. 2023 Mar;
13(2):225-232.
PMID: 36950492
Background & Aims: Severe alcoholic hepatitis (SAH) is a grave condition, and the presence of acute kidney injury (AKI) further jeopardizes patient survival. However, the impact of AKI on survival...
10.